Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 2

Conditions

Breast Neoplasms 395Neoplasms 338Prostatic Neoplasms 189Lung Neoplasms 176Colorectal Neoplasms 143Motor Activity 88Uterine Cervical Neoplasms 75Pancreatic Neoplasms 74Head and Neck Neoplasms 70Brain Neoplasms 69Carcinoma, Non-Small-Cell Lung 64Ovarian Neoplasms 60Carcinoma, Hepatocellular 51Rectal Neoplasms 49Colonic Neoplasms 46Glioblastoma 42Anxiety Disorders 41Precursor Cell Lymphoblastic Leukemia-Lymphoma 40Neoplasm Metastasis 40Depression 39Hematologic Neoplasms 38Glioma 36Melanoma 35Stomach Neoplasms 33Multiple Myeloma 33Disease 33Sarcoma 31Carcinoma, Renal Cell 31Urinary Bladder Neoplasms 30Pain 28

Interventions

Radiofrequency Ablation 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × Hyperaldosteronism × 90 days × Clear all
NCT05368090 2026-05-08

Endoscopic Ultrasound-guided Radiofrequency Ablation in Primary Aldosteronism

Haukeland University Hospital

Phase NA Recruiting
60 enrolled
Endocrine

Cushing Syndrome, Hyperaldosteronism, Adrenocortical Adenoma

NCT02756754 2026-05-04

ADERADHTA

University Hospital, Toulouse

Phase NA Completed
31 enrolled

ACTH Syndrome, Ectopic, Hyperaldosteronism

NCT07470580 2026-03-13

ADERADHTA2

University Hospital, Toulouse

Phase NA Not yet recruiting
134 enrolled
Endocrine

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡